Reduced survival after isoprenaline/ dopamine in d,l-propranolol intoxicated rats

Human & Experimental Toxicology

Volumn 15, Issue 2, 1996, Pages 120-128

  Toet, A E ^a,b   te Biesebeek, J D ^a   Vleeming, W ^a   Wemer, J ^a   Meulenbelt, J ^a,b   de Wildt, D J ^c  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

dopamine; isoprenaline; propranolol intoxication; survival; adrenoceptor agonists

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLENBUTEROL; FLEROBUTEROL; ISOPRENALINE; PROPRANOLOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ARTIFICIAL VENTILATION; CAUSE OF DEATH; CONTROLLED STUDY; DRUG OVERDOSE; HEMODYNAMICS; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; SURVIVAL TIME; TOXICITY; TOXICOLOGY;

ADRENERGIC BETA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ALBUTEROL; ANIMALS; BLOOD GAS ANALYSIS; BLOOD PRESSURE; CLENBUTEROL; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; GLUCAGON; HEART RATE; INJECTIONS, INTRAVENOUS; ISOPROTERENOL; MALE; OVERDOSE; POISONING; PROPRANOLOL; RANDOM ALLOCATION; RATS; RATS, WISTAR; RESPIRATION, ARTIFICIAL; STEREOISOMERISM;

EID: 0030045832     PISSN: 09603271     EISSN: None     Source Type: Journal    
DOI: 10.1177/096032719601500204     Document Type: Article

References (28)

1. Frishman W., Silverman R. Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 8. Self-poisoning with beta-adrenoceptor blocking agents: recognition and management. American Heart Journal 1979; 98: 798-811.
2. Eibs HG, Oberdisse U., Brambach U., Vergiftigungen mit Beta-Receptoren Blockern bei Kindern und Jugendlichen. Monatsschrift Kinderheilkunde 1982; 130: 292-95.
3. Weinstein RS Recognition and management of poisoning with beta-adrenergic blocking agents. Annals of Emergency Medicine 1984; 13: 1123-31.
4. Riker CD, Wright RK, Matusiak W., Tuscan BE de. Massive metoprolol ingestion associated with a fatality - a case report. Journal of Forensic Sciences 1987; 32: 1447-52.
5. Rohrig TP, Rundle DA Fatality resulting from metoprolol overdose. Journal of Analytical Toxicology 1987; 11: 231-32.
6. Admundson DE, Brodine SK A fatal case of propranolol poisoning. Drug Intelligence and Clinical Pharmacy 1988; 22: 781-82.
7. Perrot D., Bui-Xuan B., Lang J., Bouffard Y., Delafosse B., Faucon G., Motin J. A case of sotalol poisoning with fatal outcome. Clinical Toxicology 1988; 26: 389-96.
8. Suarez RV, Greenwald MS, Geraghty E. Intentional overdosage with propranolol. The American Journal of Forensic Medicine and Pathology 1988; 9: 45-47.
9. Stubelt O. Evaluation of antidotes against the acute cardiovascular toxicity of propranolol. Toxicology 1984; 31: 261-70.
10. Kahn MI, Miller MT Beta-blocker toxicity-the role of glucagon. Report of 2 cases. South African Medical Journal 1985; 67: 1062-63.
11. Critchely Jajh, Ungar A. The management of acute poisoning due to β-adrenoceptor antagonists. Medical Toxicology 1989; 4: 32-45.
12. Taboulet P., Cariou A., Berdeaux A., Bismuth C. Pathophysiology and management of self-poisoning with beta-blockers. Clinical Toxicology 1993; 31: 531-51.
13. Sangster B., Wildt DJ de, Dijk A van. A case of acebutolol intoxication. Journal of Toxicology 1984; 20: 69-77.
14. Langemeijer Jjm. Beta-blocker intoxication, an experimental study. Thesis, Utrecht, The Netherlands, 1988.
15. Langemeijer Jjm, Wildt DJ de, Groot G de, Sangster B. Respiratory arrest as main determinant of toxicity due to overdose with different beta-blockers in rat. Toxicology and Applied Pharmacology 1987; 89: 399-407.
16. Toet AE, Kuil A van der, Wildt DJ de, Sangster B. Isoproterenol a potential agonist in beta-blocker intoxication. Eurotox 1991, 1-4 September 1991, Maastricht, The Netherlands (abstract).
17. Engelhardt G. Pharmakologisches Wirkingsprofil von NAB 365 (Clebuterol), einem neuen broncholytikum mit einer selektiven Wirkung auf die β2-Rezeptoren. Arzneimittelforschung 1976; 26: 1404-20.
18. Tynan RF, Fisher MM, Isbels LS Self-poisoning with propranolol. Medical Journal of Australia 1981; 24: 82-83.
19. Lewis M., Kallenbach J., Germond C., Zaltman M., Muller F., Steyn J., Zwi S. Survival following massive overdose of adrenergic blocking agents (acebutolol and labetalol). European Heart Journal 1983; 4: 328-32.
20. Gilman AG, Rall ThW, Nies AS, Taylor P. The pharmacological basis of therapeutics. pergamon Press, eighth edition, 1990.
21. Benjamin IJ, Jalil JE, Tan LB, Cho K., Weber KT, Clark WA Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis. Circulation Research 1989; 65: 657-70.
22. Nisho H. Interactions of carteolol and other beta-adrenoceptor blocking agents with serotonin receptor subtypes. Archives internationales de pharmacodynamie et de therapie 1989; 302: 96-106.
23. Nimgaonkar VL, Green AR, Cowen PJ, Heal DJ, Grahame-Smith DG, Deakin Jfw. Studies on the mechanisms by which clenbuterol, a β-adrenoceptor agonist, enhances 5-HT-mediated behaviour and increases metabolism of 5-HT in the brain of the rat. Neuropharmacology 1983; 22: 739-49.
24. Bouthillier A., Blier P., Montigny C de. Flerobuterol, a β-adrenoceptor agonist, enhances serotonergic neurotransmission: an electrophysiological study in the rat brain. Psychopharmacology 1991; 103: 357-65.
25. Morin D., Monteau R., Hilaire G. 5-Hydroxytryptamine modulates central respiratory activity in the newborn rat: an in vitro study. European Journal of Pharmacology 1991; 192: 89-95.
26. Hayes MA, Timmins AC, Yau Ehs, Palazzo M., Hinds CJ, Watson D. Elevation of systemic oxygen delivery in the treatment of critically ill patients. New England Journal of Medicine 1994; 330: 1717-22.
27. Marik PE, Mohedin M. The contrasting effects of dopamine and norepinephrine on systemic and splanchnic oxygen utilization in hyperdynamic sepsis. JAMA 1994; 272: 1354-57.
28. Segal JM, Phang PT, Walley KR Low-dose dopamine hastens onset of gut ischemia in a porcine model of hemorrhagic shock. Journal of Applied Physiology 1992; 73: 1159-64.